» Articles » PMID: 26079947

Leupaxin Stimulates Adhesion and Migration of Prostate Cancer Cells Through Modulation of the Phosphorylation Status of the Actin-binding Protein Caldesmon

Overview
Journal Oncotarget
Specialty Oncology
Date 2015 Jun 17
PMID 26079947
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

The focal adhesion protein leupaxin (LPXN) is overexpressed in a subset of prostate cancers (PCa) and is involved in the progression of PCa. In the present study, we analyzed the LPXN-mediated adhesive and cytoskeletal changes during PCa progression. We identified an interaction between the actin-binding protein caldesmon (CaD) and LPXN and this interaction is increased during PCa cell migration. Furthermore, knockdown of LPXN did not affect CaD expression but reduced CaD phosphorylation. This is known to destabilize the affinity of CaD to F-actin, leading to dynamic cell structures that enable cell motility. Thus, downregulation of CaD increased migration and invasion of PCa cells. To identify the kinase responsible for the LPXN-mediated phosphorylation of CaD, we used data from an antibody array, which showed decreased expression of TGF-beta-activated kinase 1 (TAK1) after LPXN knockdown in PC-3 PCa cells. Subsequent analyses of the downstream kinases revealed the extracellular signal-regulated kinase (ERK) as an interaction partner of LPXN that facilitates CaD phosphorylation during LPXN-mediated PCa cell migration. In conclusion, we demonstrate that LPXN directly influences cytoskeletal dynamics via interaction with the actin-binding protein CaD and regulates CaD phosphorylation by recruiting ERK to highly dynamic structures within PCa cells.

Citing Articles

The role of Aha1 in cancer and neurodegeneration.

Blagg B, Catalfano K Front Mol Neurosci. 2025; 17():1509280.

PMID: 39776493 PMC: 11703849. DOI: 10.3389/fnmol.2024.1509280.


Exploring the Functions of Mutant p53 through Knockout in HaCaT Keratinocytes.

Romashin D, Rusanov A, Arzumanian V, Varshaver A, Poverennaya E, Vakhrushev I Curr Issues Mol Biol. 2024; 46(2):1451-1466.

PMID: 38392212 PMC: 10887868. DOI: 10.3390/cimb46020094.


Glucocorticoid receptor-induced non-muscle caldesmon regulates metastasis in castration-resistant prostate cancer.

Virtanen V, Paunu K, Kukkula A, Niva S, Junila Y, Toriseva M Oncogenesis. 2023; 12(1):42.

PMID: 37573448 PMC: 10423232. DOI: 10.1038/s41389-023-00485-z.


High-resolution transcriptomic and epigenetic profiling identifies novel regulators of COPD.

Schwartz U, Llamazares Prada M, Pohl S, Richter M, Tamas R, Schuler M EMBO J. 2023; 42(12):e111272.

PMID: 37143403 PMC: 10267701. DOI: 10.15252/embj.2022111272.


AHSA1 Promotes Proliferation and EMT by Regulating ERK/CALD1 Axis in Hepatocellular Carcinoma.

Zhang J, Ren Z, Zheng D, Song Z, Lin J, Luo Y Cancers (Basel). 2022; 14(19).

PMID: 36230524 PMC: 9562867. DOI: 10.3390/cancers14194600.


References
1.
Hou Q, Tan H, Lim K, Lim T, Khoo A, Tan I . Identification and functional validation of caldesmon as a potential gastric cancer metastasis-associated protein. J Proteome Res. 2012; 12(2):980-90. DOI: 10.1021/pr3010259. View

2.
Hedges J, Oxhorn B, Carty M, Adam L, Yamboliev I, Gerthoffer W . Phosphorylation of caldesmon by ERK MAP kinases in smooth muscle. Am J Physiol Cell Physiol. 2001; 278(4):C718-26. DOI: 10.1152/ajpcell.2000.278.4.C718. View

3.
Watanabe K, Tajino T, Sekiguchi M, Suzuki T . h-Caldesmon as a specific marker for smooth muscle tumors. Comparison with other smooth muscle markers in bone tumors. Am J Clin Pathol. 2000; 113(5):663-8. DOI: 10.1309/jnqx-f4km-q0q0-7xk8. View

4.
Wang Z, Yang Z . Casein kinase II phosphorylation of caldesmon downregulates myosin-caldesmon interactions. Biochemistry. 2000; 39(36):11114-20. DOI: 10.1021/bi0006767. View

5.
Turner C . Paxillin interactions. J Cell Sci. 2000; 113 Pt 23:4139-40. DOI: 10.1242/jcs.113.23.4139. View